Vikram Arora

Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Patrick L. Iversen, Vikram Arora, AJ Acker et al. · PubMed · 2003 · 144 citations

Medicine, Oncology, Pharmacology +14

<i>In vivo</i> Bioavailability and Pharmacokinetics of a <i>c-MYC</i> Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors

Gayathri R. Devi, Tomasz M. Beer, Christopher L. Corless et al. · Clinical Cancer Research · 2005 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15

Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes

Neha J. Pagidipati, Adam J. Nelson, Lisa A. Kaltenbach et al. · JAMA · 2023 · 95 citations · Full text

Medicine, Cardiology, Chronic Disease Prevention +17

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity

Carla A. London, Harmanjatinder S. Sekhon, Vikram Arora et al. · Cancer Gene Therapy · 2003 · 94 citations

Medicine, Oncology, Pharmacology +15

Bioavailability and Efficacy of Antisense Morpholino Oligomers Targeted to c-myc and Cytochrome P-450 3A2 Following Oral Administration in Rats

Vikram Arora, Derek C. Knapp, Muralimohan T. Reddy et al. · Journal of Pharmaceutical Sciences · 2002 · 78 citations

Medicine, Pharmacokinetics, Pharmacology +13